Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

PA Marks, R Breslow - Nature biotechnology, 2007 - nature.com
In our quest to understand why dimethyl sulfoxide (DMSO) can cause growth arrest and
terminal differentiation of transformed cells, we followed a path that led us to discover …

Discovery and development of SAHA as an anticancer agent

PA Marks - Oncogene, 2007 - nature.com
The path to the discovery of suberoylanilide hydroxamic acid (SAHA, vorinostat) began over
three decades ago with our studies designed to understand why dimethylsulfoxide causes …

Epigenetic changes in cancer

K Grønbaek, C Hother, PA Jones - Apmis, 2007 - Wiley Online Library
A cancer develops when a cell acquires specific growth advantages through the stepwise
accumulation of heritable changes in gene function. Basically, this process is directed by …

Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines

A Pledgie-Tracy, MD Sobolewski, NE Davidson - Molecular cancer …, 2007 - AACR
Sulforaphane, an isothiocyanate found in cruciferous vegetables, has been shown to induce
phase 2 detoxication enzymes and inhibit the growth of chemically induced mammary …

Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational …

P Münster, D Marchion, E Bicaku… - Journal of Clinical …, 2007 - ascopubs.org
Purpose To determine the safety, toxicity, and maximum-tolerated dose of a sequence-
specific combination of the histone deacetylase inhibitor (HDACi), valproic acid (VPA), and …

Histone deacetylase inhibitors in cancer therapy

WK Rasheed, RW Johnstone… - Expert opinion on …, 2007 - Taylor & Francis
Histones are a family of nuclear proteins that interact with DNA, resulting in DNA being
wrapped around a core of histone octamer within the nucleosome. Acetylation/deacetylation …

Valproic acid for the treatment of myeloid malignancies

A Kuendgen, N Gattermann - Cancer, 2007 - Wiley Online Library
Valproic acid (VPA) has been used as an anticonvulsant for decades. Recently, it was
demonstrated that VPA also acts as a histone deacetylase inhibitor and induces …

Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-α levels and transcriptional activity: a result of hyperacetylation and inhibition of …

W Fiskus, Y Ren, A Mohapatra, P Bali, A Mandawat… - Clinical Cancer …, 2007 - AACR
Purpose: The molecular chaperone heat shock protein (hsp)-90 maintains estrogen receptor
(ER)-α in an active conformation, allowing it to bind 17β-estradiol (E2) and transactivate …

Histone deacetylase inhibitors: biology and mechanism of action

JM Mehnert, WK Kelly - The Cancer Journal, 2007 - journals.lww.com
Histone deacetylases (HDACs) and histone acetyltransferases are enzymes that regulate
chromatin structure and function through the removal and addition, respectively, of the acetyl …

Inactivation of NF-κB by 3, 3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells

KMW Rahman, S Ali, A Aboukameel, SH Sarkar… - Molecular cancer …, 2007 - AACR
Constitutive activation of Akt or nuclear factor-κB (NF-κB) has been reported to play a role in
de novo resistance of cancer cells to chemotherapeutic agents, which is a major cause of …